StockWatch
·

NORRIS MEDICINES LTD. Q4 FY25 Results

NORRISQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue2.72146.0%
Total Income2.77149.4%
Expenditure2.94111.0%
PBT-0.1740.0%
Net Profit-0.2319.0%
OPM2.59%51.69pp
NPM-8.26%17.17pp
EPS0.23182.1%
View full financials

Informational and educational content only. Not investment advice.